Vimarsana
Biggest News Aggregation in the World

Test Accuracy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Test Accuracy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Test Accuracy Today - Breaking & Trending Today

Paternity Testing - Whose Baby Is It Anyway? - Benefits - Types - Vimarsana News

Paternity Testing - Whose Baby Is It Anyway? - Benefits - Types

Paternity testing involves DNA studies that are carried out under certain circumstances to establish the paternity of a child.

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore - Vimarsana News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing SINGAPORE, Feb. 21, 2024 /PRNewswire/ -- BD , a leading global medical technology company, today...

Paternity Testing - Whose Baby Is It Anyway? - Benefits - Types - Vimarsana News

Paternity Testing - Whose Baby Is It Anyway? - Benefits - Types

Paternity testing involves DNA studies that are carried out under certain circumstances to establish the paternity of a child.

Beware of Unreliable Data in Model Evaluation: A LLM Prompt Selection case study with Flan-T5 - Vimarsana News

Beware of Unreliable Data in Model Evaluation: A LLM Prompt Selection case study with Flan-T5

You may choose suboptimal prompts for your LLM (or make other suboptimal choices via model evaluation) unless you clean your test data.

BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples - Vimarsana News

BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples

Share this article Share this article FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry's first self-collection claim for HPV screening has been CE marked to the IVD directive 98/79/EC. The new claim allows laboratories and facilities to process self-collected samples via a BD diluent tube using the BD Onclarity™ HPV Assay on either the BD Viper™ LT or the BD COR™ System. The BD Viper™ LT is in use globally and the BD COR™ System, launched last year, is in use a...